Inner Cosmos
Company · United States
Developing a minimally invasive skull-mounted stimulator to treat depression, tested in early clinical studies.
In the news
Clinical trialsNeuromodulation
Inner Cosmos reports early results for its skull-embedded depression implant
In a three-person FDA early feasibility study, all participants improved and two reached remission, according to the company.